Argireline and Matrixyl for GLP-1–Induced Skin Laxity: Can Topical Peptides Restore Elasticity?
Rapid weight loss from GLP-1 agonists can cause skin laxity. Argireline and Matrixyl are topical peptides studied for wrinkles, but can they restore
This site contains research peptide compounds intended strictly for in-vitro use. You must be 18 years of age or older to continue.
By entering you confirm you are of legal age in your region. All products are for Research Use Only — not for human consumption.
You must be 18 or older to enter.
Redirecting you now…
Research, guides, and insights on peptide science.
Rapid weight loss from GLP-1 agonists can cause skin laxity. Argireline and Matrixyl are topical peptides studied for wrinkles, but can they restore
Exploring whether Argireline and GHK-Cu can work together to promote hair regrowth by mimicking minoxidil’s effects, potentially avoiding the initial
As summer nears, interest in tanning injections like Melanotan II and PT-141 grows. We review the research on safety, the recent FDA panel vote, and
Examining preclinical and clinical data on Argireline's safety after an FDA advisory committee vote, and whether this topical peptide carries any risk of
An FDA panel vote on peptide compounding has raised questions about topical peptides like Argireline and Matrixyl. We examine the research on their
Argireline is a synthetic peptide that claims to relax expression lines like crow’s feet without injections. Small human trials show modest wrinkle reduction